Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III Trial

Eric Pujade-Lauraine; Felix Hilpert; B'atrice Weber; Alexander Reuss; Andres Poveda; Gunnar Kristensen; Roberto Sorio; Ignace Vergote; Petronella Witteveen; Aristotelis Bamias; Deolinda Pereira; Pauline Wimberger; Ana Oaknin; Mansoor Raza Mirza; Philippe Follana; David Bollag; Isabelle Ray-Coquard

doi:10.1200/JCO.2013.51.4489

Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III Trial

Eric Pujade-Lauraine, Felix Hilpert, B'atrice Weber, Alexander Reuss, Andres Poveda, Gunnar Kristensen, Roberto Sorio, Ignace Vergote, Petronella Witteveen, Aristotelis Bamias, Deolinda Pereira, Pauline Wimberger, Ana Oaknin, Mansoor Raza Mirza, Philippe Follana, David Bollag, Isabelle Ray-Coquard

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	402-404
Number of pages	3
Journal	Obstetrical and Gynecological Survey
Volume	69
Issue number	7
DOIs	https://doi.org/10.1200/JCO.2013.51.4489
Publication status	Published - 1 Jul 2014

Access to Document

10.1200/JCO.2013.51.4489

Cite this

Pujade-Lauraine, E., Hilpert, F., Weber, B., Reuss, A., Poveda, A., Kristensen, G., Sorio, R., Vergote, I., Witteveen, P., Bamias, A., Pereira, D., Wimberger, P., Oaknin, A., Mirza, M. R., Follana, P., Bollag, D., & Ray-Coquard, I. (2014). Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III Trial. Obstetrical and Gynecological Survey, 69(7), 402-404. https://doi.org/10.1200/JCO.2013.51.4489

@article{a7ffd01bc2124643a1f27a7b4a5d9ea7,

title = "Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III Trial",

author = "Eric Pujade-Lauraine and Felix Hilpert and B'atrice Weber and Alexander Reuss and Andres Poveda and Gunnar Kristensen and Roberto Sorio and Ignace Vergote and Petronella Witteveen and Aristotelis Bamias and Deolinda Pereira and Pauline Wimberger and Ana Oaknin and Mirza, {Mansoor Raza} and Philippe Follana and David Bollag and Isabelle Ray-Coquard",

year = "2014",

month = jul,

day = "1",

doi = "10.1200/JCO.2013.51.4489",

language = "English",

volume = "69",

pages = "402--404",

journal = "Obstetrical and Gynecological Survey",

issn = "0029-7828",

publisher = "Lippincott Williams & Wilkins",

number = "7",

}

Pujade-Lauraine, E, Hilpert, F, Weber, B, Reuss, A, Poveda, A, Kristensen, G, Sorio, R, Vergote, I, Witteveen, P, Bamias, A, Pereira, D, Wimberger, P, Oaknin, A, Mirza, MR, Follana, P, Bollag, D & Ray-Coquard, I 2014, 'Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III Trial', Obstetrical and Gynecological Survey, vol. 69, no. 7, pp. 402-404. https://doi.org/10.1200/JCO.2013.51.4489

Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III Trial. / Pujade-Lauraine, Eric; Hilpert, Felix; Weber, B'atrice et al.
In: Obstetrical and Gynecological Survey, Vol. 69, No. 7, 01.07.2014, p. 402-404.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer

T2 - The AURELIA open-label randomized phase III Trial

AU - Pujade-Lauraine, Eric

AU - Hilpert, Felix

AU - Weber, B'atrice

AU - Reuss, Alexander

AU - Poveda, Andres

AU - Kristensen, Gunnar

AU - Sorio, Roberto

AU - Vergote, Ignace

AU - Witteveen, Petronella

AU - Bamias, Aristotelis

AU - Pereira, Deolinda

AU - Wimberger, Pauline

AU - Oaknin, Ana

AU - Mirza, Mansoor Raza

AU - Follana, Philippe

AU - Bollag, David

AU - Ray-Coquard, Isabelle

PY - 2014/7/1

Y1 - 2014/7/1

UR - http://www.scopus.com/inward/record.url?scp=84988723862&partnerID=8YFLogxK

U2 - 10.1200/JCO.2013.51.4489

DO - 10.1200/JCO.2013.51.4489

M3 - Comment/Letter to the editor

AN - SCOPUS:84988723862

SN - 0029-7828

VL - 69

SP - 402

EP - 404

JO - Obstetrical and Gynecological Survey

JF - Obstetrical and Gynecological Survey

IS - 7

ER -

Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III Trial

Access to Document

Other files and links

Cite this